Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to determine if patients with brain metastases from
non-small cell lung cancer treated with Motexafin Gadolinium and whole brain radiation
therapy retain their neurologic function and ability to think for a longer time compared to
patients treated with whole brain radiation therapy alone.